Tenaya Therapeutics, Inc. SEC filings TNYA
Tenaya Therapeutics, Inc. has 353 filings in SEC EDGAR's recent list, going back to May 7, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-8 | Employee stock plan registration | Feb 3, 2026 | — |
| 424B5 | Prospectus supplement | Dec 12, 2025 | — |
| 424B5 | Prospectus supplement | Dec 11, 2025 | — |
| S-3 | Shelf registration | Mar 21, 2025 | — |
| 424B5 | Prospectus supplement | Mar 4, 2025 | — |
| 424B5 | Prospectus supplement | Mar 3, 2025 | — |
| 424B3 | Prospectus | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 7, 2025 | — |
| S-8 | Employee stock plan registration | Sep 17, 2024 | — |
| 424B5 | Prospectus supplement | Feb 8, 2024 | — |
| S-8 | Employee stock plan registration | Jan 31, 2024 | — |
| S-8 | Employee stock plan registration | Mar 8, 2023 | — |
| 424B5 | Prospectus supplement | Nov 17, 2022 | — |
| 424B5 | Prospectus supplement | Nov 16, 2022 | — |
| 424B5 | Prospectus supplement | Aug 17, 2022 | — |
| S-3 | Shelf registration | Aug 10, 2022 | — |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| S-8 | Employee stock plan registration | Jul 30, 2021 | — |
| 424B4 | Prospectus | Jul 30, 2021 | — |
| S-1MEF | Filing | Jul 29, 2021 | — |
| S-1/A | Amended registration statement | Jul 26, 2021 | — |
| S-1 | Registration statement | Jul 9, 2021 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TNYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1858848
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.